Susquehanna International Group
ROSG

Susquehanna International Group’s Rosetta Genomics Ltd. ROSG Stock Holding History

Susquehanna International Group’s Portfolio ROSG Stock Details ROSG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-36,171
Closed -$20K – 10864
2017
Q4 		$20K Buy
+36,171
New +$28.4K ﹤0.01% 9069
2016
Q3 		– Sell
-1,783
Closed -$25K – 9517
2016
Q2 		$25K Buy
1,783
+570
+47% +$8.12K ﹤0.01% 8357
2016
Q1 		$16K Buy
+1,213
New +$15.5K ﹤0.01% 8844
2015
Q1 		– Sell
-1,255
Closed -$34K – 10351
2014
Q4 		$34K Sell
1,255
-3,125
-71% -$101K ﹤0.01% 9438
2014
Q3 		$186K Sell
4,380
-361
-8% -$16.4K ﹤0.01% 8748
2014
Q2 		$247K Buy
4,741
+2,839
+149% +$141K ﹤0.01% 8710
2014
Q1 		$114K Buy
+1,902
New +$98.2K ﹤0.01% 8525

Other funds holding ROSG

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HCM
Highlander Capital Management Short Hills, New Jersey $292M AUM 22.24% 1-Year Est. Return

Susquehanna International Group's ROSG Position: Q1 2018 in Review

Susquehanna International Group sold out of Rosetta Genomics Ltd. (ROSG) in Q1 2018, closing a stake of 36,171 shares — an estimated $20K sold.

Susquehanna International Group first reported a position in ROSG in Q1 2014 and held it in 7 quarters. The position peaked at $247K in Q2 2014. 8 funds tracked by Wall St. Rank hold ROSG as of Q1 2018.

  • Susquehanna International Group reported no remaining Rosetta Genomics Ltd. position as of Q1 2018 after selling out during the quarter.
  • Susquehanna International Group sold 36,171 Rosetta Genomics Ltd. shares in Q1 2018, an estimated $20K.
  • Susquehanna International Group first reported a position in Rosetta Genomics Ltd. in Q1 2014 and held it in 7 quarters.
  • Susquehanna International Group's Rosetta Genomics Ltd. position peaked at $247K in Q2 2014.
  • 8 funds tracked by Wall St. Rank held Rosetta Genomics Ltd. as of Q1 2018.

Based on Susquehanna International Group's 13F filing for Q1 2018, filed 15 May 2018.